Results 131 to 140 of about 663,256 (217)

“The impact of debulking surgery in patients with node-positive epithelial ovarian cancer: Analysis of prognostic factors related to overall survival and progression-free survival after an extended long-term follow-up period”

, 2016
Augusto Pereira, Tirso Pérez‐Medina, Javier F. Magrina, Paul M. Magtibay, Ana Rodríguez-Tapia, Tatiana Cuesta-Guardiola, Irene Peregrin, Elsa Mendizábal, Santiago Lizarraga, Luís Ortiz-Quintana   +9 more
openalex   +1 more source

Progression‐free survival of children with localized ependymoma treated with intensity‐modulated radiation therapy or proton‐beam radiation therapy [PDF]

, 2017
Mariko Sato, Jillian R. Gunther, Anita Mahajan, Eunji Jo, Arnold C. Paulino, Adekunle M. Adesina, Jeremy Jones, Leena Ketonen, Jack Su, M. Fatih Okcu, Soumen Khatua, Robert C. Dauser, William E. Whitehead, Jeffrey S. Weinberg, Murali Chintagumpala   +14 more
openalex   +1 more source

Patient-reported outcomes as prognostic indicators for overall survival and progression-free survival in brain tumor patients - a systematic review and meta-analysis of randomized clinical trials. [PDF]

J Neurooncol
Sanikommu S, Santos AN, Wipplinger C, Dawoud B, Komotar RJ, Lu VM.   +5 more
europepmc   +1 more source

Pre-treatment cytokines plus TPSA predict biochemical progression-free survival in prostate cancer metastasis and discriminate metastatic status: a retrospective study. [PDF]

Front Immunol
Mao KF, Sun J, Sun C, Sun BB, Wu ZG, Cai J, Zhou CF.   +6 more
europepmc   +1 more source

Evaluation of progression-free survival as a surrogate endpoint for overall survival in small cell lung cancer: a systematic review. [PDF]

J Thorac Dis
Lin G, Ge F, Yang C, Huang Y.
europepmc   +1 more source

Etoposide combined with anlotinib and sintilimab successfully achieved long term progression-free survival in platinum-refractory ovarian cancer: A case report. [PDF]

Gynecol Oncol Rep
Zhang L, Wang Y, Qiu C, Li Y, Zhao K, Yuan X, Liu Y, Lu P, Zhang M.   +8 more
europepmc   +1 more source

Computed tomography-based unsupervised clustering identifies clusters associated with progression free survival in clear cell renal cell carcinoma. [PDF]

Cancer Imaging
Park JH, Choi D, Lee C, Kim CG, Kim S, Jung M, Yoon J.   +6 more
europepmc   +1 more source

Determinants of 15-Year Progression-Free Survival in Multiple Myeloma; Real-World Data From a Single Institution. [PDF]

Am J Hematol
Dimopoulos MA, Ntanasis-Stathopoulos I, Fotiou D, Theodorakakou F, Solia E, Spiliopoulou V, Malandrakis P, Psimenou E, Giannouli S, Kanellias N, Koutoulidis V, Roussou M, Andrikopoulou A, Migkou M, Eleutherakis-Papaiakovou E, Gavriatopoulou M, Terpos E, Kastritis E.   +17 more
europepmc   +1 more source

Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT‐2 follow‐up and post‐hoc analyses on progression‐free survival and tumour growth

, 2017
Meletios Α. Dimopoulos, Sagar Lonial, Darrell White, Philippe Moreau, Antonio Palumbo, Jesús F. San Miguel, Ofer Shpilberg, Kenneth C. Anderson, Sebastian Grosicki, Ivan Špıčka, Adam Walter‐Croneck, Hila Magen, María‐Victoria Mateos, Andrew R. Belch, Donna Reece, Meral Beksaç, Eric Bleickardt, Valerie Poulart, Jennifer Sheng, Oumar Sy, Jessica Katz, Anil Singhal, Paul G. Richardson   +22 more
openalex   +1 more source

Molecular tumor volume on PSMA PET/CT is an independent imaging biomarker associated with progression-free survival in patients with oligorecurrent prostate cancer. [PDF]

Am J Nucl Med Mol Imaging
Cheng M, Mahmood U, Mercaldo ND, Esfahani SA, Ng T, Gao X, Efstathiou JA, Heidari P.   +7 more
europepmc   +1 more source